Kremezin (AST-120) delays the progression of diabetic nephropathy in Japanese type 2 diabetic patients

Diabetes Care. 2005 Oct;28(10):2590. doi: 10.2337/diacare.28.10.2590.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Carbon / administration & dosage*
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetic Nephropathies / drug therapy*
  • Humans
  • Japan
  • Oxides / administration & dosage*
  • Treatment Outcome

Substances

  • Oxides
  • Carbon
  • AST 120